Multiple myeloma

You have access
Self-differentiated Dendritic Cells Presenting NY-ESO-1 Prime Cytotoxic T Cells for the Treatment of Multiple Myeloma
DANAI SAMUTPRADIT, PHURIN AREESAWANGKIT, PRANAIDEJ HENGSWAT, WANNASIRI CHIRAPHAPPHAIBOON, PLOYPLOEN PHIKULSOD, KORNKAN CHOOME, NATTAPORN PHANTHAPHOL, YUPANUN WUTTI-IN, MUTITA JUNKING, SANYA SUKPANICHNANT, THAWEESAK CHIEOCHANSIN and PA-THAI YENCHITSOMANUS

Anticancer Research January 2026, 46 (1) 249-262; DOI: https://doi.org/10.21873/anticanres.17939
Open Access
Akt Regulates Extracellular Vesicle Secretion in Hypoxia-adapted Multiple Myeloma RPMI8226 Cells
YUKI TODA, SAYAKA NAKAYAMA, YUNA YAMAMOTO, ASUKA FUJIMOTO, SHIGEKUNI HOSOGI and EISHI ASHIHARA

Anticancer Research April 2025, 45 (4) 1355-1366; DOI: https://doi.org/10.21873/anticanres.17521
Open Access
Genetic Alteration of p18^INK4C and its Expression in Peripheral Blood Mononuclear Cells Were Not Associated With Progression-free Survival of Multiple Myeloma Patients After Autologous Stem Cell Transplant
JUNAN LI and MING J. POI

Anticancer Research September 2024, 44 (9) 3771-3776; DOI: https://doi.org/10.21873/anticanres.17201
You have access
Novel Midkine Inhibitor Induces Cell Cycle Arrest and Apoptosis in Multiple Myeloma
KODCHARAT CHEEVAPRUK, MIKINORI UENO, PRIN SUNGWAN, GUNYA SITTITHUMCHAREE, RYUSHO KARIYA, SOMPONNAT SAMPATTAVANICH and SEIJI OKADA

Anticancer Research March 2024, 44 (3) 1023-1031; DOI: https://doi.org/10.21873/anticanres.16897
Open Access
Hypoxia-adapted Multiple Myeloma Stem Cells Resist γδ-T-Cell-mediated Killing by Modulating the Mevalonate Pathway
YUSUKE SANO, NAOKO KUWABARA, SAORI NAKAGAWA, YUKI TODA, SHIGEKUNI HOSOGI, SHINJI SATO and EISHI ASHIHARA

Anticancer Research February 2023, 43 (2) 547-555; DOI: https://doi.org/10.21873/anticanres.16191
Open Access
Measurable Residual Disease Assessment Using Next-Generation Flow in Patients With Relapsed and Refractory Multiple Myeloma Treated With a Combination of Carfilzomib, Lenalidomide, and Dexamethasone
TAKESHI YOROIDAKA, TAKESHI YAMASHITA, RYOICHI MURATA, KYOKO YOSHIHARA, SATOSHI YOSHIHARA, MIKIO UEDA, SHINJI NAKAO, KOSEI MATSUE and HIROYUKI TAKAMATSU

Anticancer Research January 2023, 43 (1) 157-165; DOI: https://doi.org/10.21873/anticanres.16145
Open Access
Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years
NORMANN STEINER, PAULA SCHOBER, WOLFGANG WILLENBACHER, BRIGITTE KIRCHER, EBERHARD GUNSILIUS, DOMINIK WOLF and DAVID NACHBAUR

Anticancer Research December 2022, 42 (12) 5825-5832; DOI: https://doi.org/10.21873/anticanres.16090
You have access
Cytotoxic T Cells Activated by Self-differentiated Monocyte-derived Dendritic Cells Against Multiple Myeloma Cells
WANNASIRI CHIRAPHAPPHAIBOON, PIRIYA LUANGWATTANANUN, AUSSARA PANYA, NIPHAT JIRAPONGWATTANA, PRIMANA PUNNAKITIKASHEM, THAWEESAK CHIEOCHANSIN, MUTITA JUNKING and PA-THAI YENCHITSOMANUS

Anticancer Research April 2022, 42 (4) 1785-1799; DOI: https://doi.org/10.21873/anticanres.15655
You have access
A Single Nucleotide Polymorphism (SNP) in the SLC22A3 Transporter Gene Is Associated With the Severity of Oral Mucositis in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplant Followed by Melphalan Therapy
JUNAN LI, AVINASH K. PERSAUD, JASMINE A. JOHNSON, DOUGKAS W. SBOROV, MITCH A. PHELPS, CRAIG C. HOFMEISTER and MING J. POI

Anticancer Research January 2022, 42 (1) 385-395; DOI: https://doi.org/10.21873/anticanres.15497
You have access
Aggressive Plasmablastic Myeloma With Extramedullary Cord Compression and Hyperammonemic Encephalopathy: Case Report and Literature Review
KINGSLEY DAH, JONATHAN L. LAVEZO and FATMA DIHOWM

Anticancer Research November 2021, 41 (11) 5839-5845; DOI: https://doi.org/10.21873/anticanres.15403

Main menu

User menu

Search

Multiple myeloma

Pages